Author Archives for UroLift

Teleflex Reports 250,000 Patients Treated for Enlarged Prostate With the Minimally Invasive UroLift® System

March 10, 2021 12:28 pm by UroLift

March 9, 2021 Teleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated with the UroLift® System, a proven,... Read More

Published Data Demonstrate Sexual Function Improvement and Preservation with the Minimally Invasive UroLift® System Compared to Medications Prescribed for Benign Prostatic Hyperplasia

January 22, 2021 12:31 pm by UroLift

WAYNE, Pa.— January 20, 2021—Teleflex Incorporated (NYSE: TFX) announced today that new data published in the peer-reviewed journal, European Urology Focus,... Read More

Research Reinforcing the Effectiveness and Safety of the UroLift® System in the Real-World Setting Presented at 50th Annual ICS Meeting

November 24, 2020 3:08 am by UroLift

New Findings Show UroLift System Same-Day Outpatient Procedure Demonstrates Symptom Improvement for Benign Prostatic Hyperplasia WAYNE, Pa.— November 19, 2020 – Teleflex Incorporated (NYSE: TFX) today announced the results of four studies that were accepted at the ICS 2020 Annual Meeting – Online reinforcing the safety and efficacy of the UroLift® System for the treatment of benign prostatic hyperplasia (BPH).... Read More

Teleflex Announces Positive Data Emphasizing the Effectiveness of the UroLift® System Treatment for Enlarged Prostate Across Broad Patient Populations

July 22, 2020 2:35 am by UroLift

Data Presented at European Association of Urology Highlights Safety and Versatility of the Minimally Invasive UroLift System in a Real-World Setting ... Read More

Teleflex Announces Publication of Early Patient Experience Data Highlighting the UroLift® System as a Superior Treatment to Rezum™ Steam Injection in Patients with Enlarged Prostate

July 2, 2020 3:49 am by UroLift

Data Shows Minimally Invasive Treatment Provides Rapid Symptom Relief, Allowing Men to Return to Daily Activities Quickly WAYNE, Pa.— June 22,... Read More

Teleflex Announces Positive Data Showing that the UroLift® System Effectively Relieves Enlarged Prostate Symptoms While Preserving Patients’ Sexual Function*

May 19, 2020 8:44 am by UroLift

Data Presented at American Urological Association 2020 Virtual Experience Highlight Benefits and Superior Sexual Function* Preservation of the Minimally Invasive Treatment for Patients with Enlarged Prostate WAYNE,... Read More

Teleflex COVID-19 Response

April 17, 2020 1:34 am by UroLift

The Teleflex mission to improve the health and quality of people’s lives has taken on a new meaning during the COVID‑19 pandemic.... Read More

Teleflex Announces FDA Clearance for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc

January 8, 2020 2:23 am by UroLift

January 7, 2020 Minimally Invasive Procedure Now Available to Hundreds of Thousands More Men with Enlarged Prostate, Providing Safe and Effective Symptom Relief.... Read More

Teleflex Announces Urology Times Article Highlighting the UroLift System as Providing a Superior Patient Experience for Treating Enlarged Prostate

September 16, 2019 7:46 am by UroLift

Minimally Invasive Treatment Options for BPH Remain Critical Due to Shortcomings of Surgery and Medication WAYNE, Pa. –Sept. 16, 2019 – Teleflex Incorporated (NYSE: TFX) today announced the publication of an article showcasing the effectiveness and overall benefits of the minimally invasive UroLift® System treatment for patients with benign prostatic hyperplasia (BPH).... Read More

Teleflex Announces Publication of a Large Real-World Study Confirming Results from Controlled Clinical Studies of the UroLift® System

July 18, 2019 3:10 am by UroLift

Results from Multi-Center Study Support the Application of Minimally Invasive Treatment for Broader BPH Population WAYNE, Pa. – July 9,... Read More

1 2 3 … 5 Next »